Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
US stocks move: Eli Lilly surges over 6% to a record high as leukemia drug Jaypirca receives positive recommendation from the European Union’s CHMP

US stocks move: Eli Lilly surges over 6% to a record high as leukemia drug Jaypirca receives positive recommendation from the European Union’s CHMP

格隆汇格隆汇2026/06/26 14:40
Show original
Golden Globe June 26|A certain exchange surged by more than 6%, reaching $1,200.55, marking a record high. In terms of news, the company announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of its non-covalent Bruton’s tyrosine kinase (BTK) inhibitor Jaypirca, for the treatment of adult chronic lymphocytic leukemia (CLL) patients who have received or not received BTK inhibitor therapy. This recommendation covers the entire line of treatment for this indication.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!